13F
中

HALO HALOZYME THERAPEUTICS INC

2026Q1 · CUSIP 40637H109 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
627
Δ holders QoQ
+16
Breadth percentile
Top 19%
Whale holders
238
Δ whales
-2
Inst. holding value
$7.7B
New positions
97
Closed positions
81
Price momentum (1Q)
-16.2%
Put / Call
8/9

Breadth history (34 quarters)

2018Q1: Δ+10 · h=206 2018Q2: Δ-16 · h=190 2018Q3: Δ+3 · h=193 2018Q4: Δ-1 · h=192 2019Q1: Δ+8 · h=200 2019Q2: Δ+1 · h=201 2019Q3: Δ+11 · h=212 2019Q4: Δ+13 · h=225 2020Q1: Δ-15 · h=210 2020Q2: Δ+51 · h=261 2020Q3: Δ+2 · h=263 2020Q4: Δ+71 · h=334 2021Q1: Δ-6 · h=328 2021Q2: Δ-18 · h=310 2021Q3: Δ+9 · h=319 2021Q4: Δ-1 · h=318 2022Q1: Δ-7 · h=311 2022Q2: Δ+49 · h=360 2022Q3: Δ-6 · h=354 2022Q4: Δ+73 · h=427 2023Q1: Δ-44 · h=383 2023Q2: Δ-15 · h=368 2023Q3: Δ+19 · h=387 2023Q4: Δ+20 · h=407 2024Q1: Δ+2 · h=409 2024Q2: Δ+48 · h=457 2024Q3: Δ+51 · h=508 2024Q4: Δ+1 · h=509 2025Q1: Δ+39 · h=548 2025Q2: Δ+0 · h=548 2025Q3: Δ+55 · h=603 2025Q4: Δ+8 · h=611 2026Q1: Δ+16 · h=627 2018Q1: holders=206 2018Q2: holders=190 2018Q3: holders=193 2018Q4: holders=192 2019Q1: holders=200 2019Q2: holders=201 2019Q3: holders=212 2019Q4: holders=225 2020Q1: holders=210 2020Q2: holders=261 2020Q3: holders=263 2020Q4: holders=334 2021Q1: holders=328 2021Q2: holders=310 2021Q3: holders=319 2021Q4: holders=318 2022Q1: holders=311 2022Q2: holders=360 2022Q3: holders=354 2022Q4: holders=427 2023Q1: holders=383 2023Q2: holders=368 2023Q3: holders=387 2023Q4: holders=407 2024Q1: holders=409 2024Q2: holders=457 2024Q3: holders=508 2024Q4: holders=509 2025Q1: holders=548 2025Q2: holders=548 2025Q3: holders=603 2025Q4: holders=611 2026Q1: holders=627 -73 -36.5 +0 +36.5 +73 171415659 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 11 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 19% — —
2025Q3 Top 4% +2.1% -2.2%
2025Q1 Top 4% +31.3% +32.4%
2024Q3 Top 4% +35.7% +26.3%
2024Q2 Top 3% -9.2% -2.8%
2023Q3 Top 9% -8.9% +13.8%
2022Q4 Top 4% -32.4% -12.2%
2022Q2 Top 1% +21.2% +10.6%

Options Sentiment

Put holders
8
QoQ: +1
Call holders
9
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
26.5
EPS (TTM)
$2.85
EPS YoY
-24.2%
Revenue (TTM)
$1.5B
Revenue YoY
+39.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $152M 2022-09-30: $209M 2022-12-31: $181M 2023-03-31: $162M 2023-06-30: $221M 2023-09-30: $216M 2023-12-31: $230M 2024-03-31: $196M 2024-06-30: $231M 2024-09-30: $290M 2024-12-31: $298M 2025-03-31: $265M 2025-06-30: $326M 2025-09-30: $354M 2025-12-31: $452M 2026-03-31: $377M 2022-06-30: EPS 0.16 2022-09-30: EPS 0.44 2022-12-31: EPS 0.41 2023-03-31: EPS 0.29 2023-06-30: EPS 0.56 2023-09-30: EPS 0.61 2023-12-31: EPS 0.64 2024-03-31: EPS 0.60 2024-06-30: EPS 0.72 2024-09-30: EPS 1.05 2024-12-31: EPS 1.06 2025-03-31: EPS 0.93 2025-06-30: EPS 1.33 2025-09-30: EPS 1.43 2025-12-31: EPS -1.13 2026-03-31: EPS 1.22 0M 226M 452M $M -1.24 0.17 1.57 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 19 2023-03-31: PE 25.72023-06-30: PE 25.52023-09-30: PE 21.12023-12-31: PE 17.22024-03-31: PE 18.62024-06-30: PE 23.12024-09-30: PE 15.22024-12-31: PE 172025-03-31: PE 13.82025-06-30: PE 15.42025-09-30: PE 14.72025-12-31: PE 312026-03-31: PE 23.6 12 22 33 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)